Post herpetic neuralgia (PHN)

Evidence-based neurology checklist on post herpetic neuralgia (phn): Characteristics This is persistence of herpes zoster pain for >3 months after resolution of the rash It occurs in 10-15% of cases Risk factors Treatments

Characteristics

  • This is persistence of herpes zoster pain for >3 months after resolution of the rash
  • It occurs in 10-15% of cases

Risk factors

Treatments

References

  1. Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H. Practice parameter: treatment of postherpetic neuralgia. Ann evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004; 63:959-965.
  2. Jung BF, Johnson RW, Griffin DRJ, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004; 62:1545-1551.
  3. Forbes HJ, Bhaskaran K, Thomas SL, et al. Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: a cohort study. Neurology 2016; 87:94-102. 
  4. Alper BS, Lewis PR. Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia? a systematic review of the literature. J Fam Pract 2000; 49:255-264.
  5. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17:1113-1123.
  6. And 1 more. Subscribe to see the full list

Related checklists

Loading...